Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006]期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006]

Authors:	F Vaylet A Bonnichon Y Salles E Gontier G Bonardel H Lefloch A Mairovitz M Mantzarides A Niang C Marotel H Foehrenbach

Institution:	1. Pôle pharmacie, Centre Hospitalier Universitaire Grenoble Alpes, France;2. Université Grenoble Alpes, Grenoble, France;3. Univ. Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC, 38000 Grenoble, France;4. Univ. Grenoble Alpes, Inserm, CHU Grenoble Alpes, HP2, 38000 Grenoble, France;5. General Cancer Registry of Isère, Grenoble, France;6. Centre de Coordination en Cancérologie, Pavillon E.Chatin, CHU Grenoble Alpes;7. Institute for Advanced Biosciences, UGA/INSERM U1209/CNRS 5309, Université Grenoble Alpes, France;8. Clinique de Pneumologie, Unité d''Oncologie Thoracique, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, France

Abstract:	Technological progress and numerous published studies allow to estimate the best place of the 18F-fluorodeoxyglucose positron emission tomography, a real functional metabolic imagery, in the clinical and therapeutic strategy of non small cell lung cancers.

Keywords:
本文献已被 ScienceDirect 等数据库收录！